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tosus (SLE), 20,21 etc. However, the literature regarding IL-10 polymorphsims and CALs in KD is limited. 14,15, 22 The study by Yang et al showed that the ATA haplotype might be regarded as a genetic risk factor for CALs in KD, nevertheless the relationship of various genotypes for 3 single nucleotide polymorphisms (SNPs) and CALs were not evaluated yet. 14 Jin et al demonstrated that the IL-10 -627 A/C in promoter polymorphism might be a genetic risk marker for early CALs in KD, but they did not evaluate the effect of these 3 common polymorphisms on risk of CALs. 15 In contrast, Hsueh et al reported that no significant difference was observed in the genotype and allelic frequencies for the IL-10 -592 A/C polymorphism between KD patients with and without CALs. 22 In this study, we investigated whether IL-10 gene promoter -1082 A/G, -819 T/C, and -592 A/C polymorphisms are associated with development of CALs in the acute or chronic stage for Taiwanese KD children.
Methods
This study was carried out at the Department of Pediatrics, Kaohsiung Veterans General Hospital (KVGH), Taiwan. A total of 751 patients diagnosed with or ruled out of KD, from 1990 to 2008, were invited to participate in this study. Of these eligible participants, 532 (74.4%) KD patients' parents were approached, either by phone call or in an outpatient follow-up. One hundred and eighty-eight (25.0%) patients' parents refused to take part in this study and only 344 (45.8%) patients' parents gave written informed consent and blood samples were collected. After reviews of 344 patients' medical records, only 279 (81.1%) were recruited in this study because their records were with complete clinical data and met the criteria for KD. This study was approved by the Institutional Review Board of KVGH.
Medical records were reviewed for age, sex, presenting symptoms, times of IVIG treatment (2 gm · kg -1 · dose -1 ), complications, and laboratory data, including baseline white blood cell (WBC) with differential count (neutrophil, lymphocyte, and band), platelet count, concentrations of the following: hemoglobin, alanine aminotransferase, aspartate aminotransferase, and C-reactive protein within 7 days of illness. All KD children underwent 2-dimensional echocardiography at the time of diagnosis and again at weeks 2, 4 and 8 after treatment, and annually in follow-up. CALs in the acute and chronic stage are defined as CALs within 2 weeks of illness and beyond 1 year, separately. The patients were divided into those with and without CALs in the acute stage. Then, KD children with CALs in the acute stage were further divided into those with and without CALs in the chronic stage. The internal diameter of the coronary arteries was measured and CALs were defined as follows: coronary arteries were classified as abnormal if the internal lumen diameter was ≥3 mm in children younger than 5 years old or ≥4 mm in children older than 5 years old, if the internal diameter of a segment measured 1.5 times that of an adjacent segment, or if the coronary lumen was clearly irregular. 23 Two senior pediatric cardiologists independently assessed the images. For evaluation of intra-and inter-rater reliabilities, a random sample of 40 patients' measurements was taken twice on different occasions by the same and by these two different pediatric cardiologists. Kappa coefficients were 0.943 (P<0.001) and 0.914 (P<0.001) for intra-and inter-rater reliabilities, respectively.
Polymorphism Genotyping
Genomic DNA for genotyping was extracted and purified from whole-blood samples of all subjects by use of PUREGENE DNA purification kits (Gentra, 2008) . The detection of genotypes of IL-10 SNPs in -1082 A/G, -819 T/C and -592 A/C were performed by the TaqMan real-time polymerase chain reaction (PCR) method, and then analyzed by ABI PRISM 7500 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) in 96-well format. PCR reactions were carried out in a reaction mixes containing 10 ng DNA, 5 μl 2x TaqMan Universal PCR Master Mix (Applied Biosystems), 0.5 μl 20x Primer/Probe mixture, and ddH2O to a final volume of 10 μl. The PCR program was as follows: 95°C for 10 min, followed by 40 cycles of 15 s at 92°C, and 1 min at 60°C. One control without DNA template in each 96-well format was used for quality-control procedure. The allelic-specific fluorescence data from each plate were analyzed using the SDS v1.3.1 software (Applied Biosystems, 2005) to automatically determine the genotype of each sample. A 5% random sample of genotypes were repeated for each locus, and results were 100% concordant to the initial analysis.
Statistical Analysis
Demographic and clinical data between patients with/without CALs were compared by the chi-square test or Student's t-test. Genotype and allele frequencies of IL-10 were compared between patients with/without CALs using the chisquare test or Fisher's exact test when appropriate. For each tested SNP, departure from Hardy -Weinberg equilibrium in patients without CALs was evaluated by comparing the observed to the expected genotype frequencies using a goodness of fit chi-squared test. The haplotypes and their frequencies were estimated with SAS/Genetics (Version 9.1.3; SAS Institute, Cary, NC, USA) based on the expectation-maximization algorithm. 24 In addition, multiple logistic regression was used to evaluate the association between allele types, genotypes, and haplotypes of SNPs in IL-10 with CALs risk by adjusting various confounders, such as gender, age, WBC count, hemoglobin concentration, band count and times of IVIG therapy. Furthermore, the 'KD diagnosis year ' (1990-2003 cohort vs 2004-2008 cohort) was also adjusted in the multiple logistic regression model because of selection effect on patients with CALs in the chronic stage (X 2 = 5.33, df =1, P=0.021). The crude odds ratios (COR), adjusted odds ratios (AOR), and 95% confidence intervals (CI) were calculated by use of logistic regression. A P<0.05 was considered statistically significant. The statistical software package of SPSS (Version 12.0) and SAS/Genetics (Version 9.1.3) were used for all of the statistical analysis.
Results
A total of 279 patients (M/F 169/110, mean age 29.8±31.2 months) were reviewed for polymorphism analysis. They were divided into 172 without CALs, and 107 with CALs in the acute stage. Among 107 with CALs in the acute stage, 33 were with CALs in the chronic stage and 74 only with transient CALs. They were further divided into 246 without and 33 with CALs in the chronic stage. Baseline patient demographics are summarized in Table 1 .
Age, Sex, and Times of IVIG Treatment in KD Children
With and Without CALs (Table 1) The proportion of male patients in KD children with CALs in the acute stage was significantly more than that in those
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without CALs in the acute stage (P=0.039). There were no significant differences between the 2 groups in terms of age in acute stage. The proportion of older patients (>60 months) with CALs in the chronic stage was significantly more than that in those without CALs in the chronic stage (P=0.043). There were no significant differences between the 2 subgroups in terms of sex in the chronic stage. Compared to KD children without CALs in the acute stage, those with CALs in the acute stage received more times of IVIG treatment (P<0.001). Those with CALs in the chronic stage received more times of IVIG treatment than those without CALs in the chronic stage (P<0.001) ( Table 1) . (Table 2 ) There were no significant differences of laboratory data between KD children with and without CALs in the acute stage, except WBC count (P=0.027). No significant differences of laboratory data were found between those with and without CALs in the chronic stage ( Table 2) .
Laboratory Findings in KD Children With and Without CALs

Genotype and Allele Frequencies of IL-10 Polymorphisms in KD Children With and Without CALs (Table 3)
The genotype and allele frequencies of the IL-10 promoter -1082 A/G, -819 T/C and -592 A/C polymorphisms in 4 groups of KD children are shown in Table 3 (Table 4) The linkage disequilibrium was observed between the SNPs -1082 and -819 (D'=1), between the SNPs -1082 and -592 WENG KP et al. Tables 1,2 .
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(D'=1), and between the SNPs -819 and -592 (D'=1). Therefore, we analyzed the possible haplotypes constructed by the IL-10 -1082 G/A, -819 T/C and -592 A/C in KD children with and without CALs by use of 4 logistic regression models ( 
Discussion
Our study showed that associations between IL-10 genotype (-819 and -592), allelic type (-819 and -592), or 3-locus haplotype (-1086, -819, and -592) and early CALs were detected in Taiwanese KD children. Our result might support the finding that IL-10 is involved in the pathophysiology of KD. 7,9, 25 Two previous studies have demonstrated that KD patients in acute phase produce nearly 8-33-fold and 4-5-fold higher serum IL-10 concentrations than those of healthy controls and those of the acute febrile patients, respectively. 9, 25 In addition, the elevated IL-10 concentrations during acute KD decreased not only during subacute and convalescent phase, 9 but also immediately after IVIG administration, coincidently with rapid improvement of inflammatory symptoms. 25 To the best of our knowledge, this is the first study to investigate the relationship of IL-10 genetic polymorphisms (-1082, -819, -592) with CALs in both acute and chronic stage of KD. To further analyze the putative effect of IL-10 polymorphisms on CALs in acute and chronic stage of KD, we conducted a multiple logistic regression analysis. Yang et al first reported that the ATA haplotype might be a genetic risk factor for CALs in KD. 14 In this series, the ATA haplotype is still the most prevalent. However, the COR of CALs in the acute stage for carriers of ATA was moderate and with small range of 95%CI as compared to those (4.26 for ATA vs non-ATA, 95%CI: 2.20-8.25) found in Yang et al's study. 14 Our results suggested that ATA haplotype might be a modest genetic factor for CALs in acute KD. Another 2 reasons can explain the discrepancy on risk level and 95%CI between Yang et al's 14 and our studies. First, the small sample size in Yang et al's study might be associated with unstable and very high odds ratio. 14 Second, the ATA frequency in KD children without CALs in the acute stage in this series was higher than that in Yang et al's survey 14 (61% vs 52%), which might be due to different ethnic groups. Previous studies also demonstrated the conflicting results about the relationships between the ATA haplotype and periodontitis 18, 19 or SLE 20,21 in the different populations.
Our results showed that IL-10 -592 C allele and CC genotype were with a significantly reduced risk of CALs in acute Abbreviations see in Tables 1-3. WENG KP et al.
stage (AOR =0.21, 0.67 separately). In contrast, Hsueh et al reported that no significant difference was observed in the genotype and allelic frequencies for the IL-10 -592 A/C polymorphism between KD patients with and without CALs. 22 Several reasons may account for the discrepancies between the 2 investigations. First, the sample size of Hsueh et al's study (n=105) is smaller than ours (n=279). 22 The statistical power to detect the association of IL-10 and CAL in Hsueh et al's study would not be enough. 22 Therefore, the failure to demonstrate a significant association in their study might be due to insufficient sample size. Second, the -592 C allele frequency in 'the group with CALs' of Hsueh et al's study was comparable to those of ours (35.5% vs 28.5%; X 2 = 6.27, df =1, X 2 =1.110, P=0.291), while the -592 C allele frequency in 'the group without CALs' of Hsueh et al's study was significantly lower than those of ours (25.0% vs 36.6%; X 2 = 5.89, df =1, X 2 =6.320, P=0.012) between the 2 studies. 22 Thus, their negative findings on association due to population stratification on disease severity could not be ruled out. Third, there might be no intra-and inter-rater reliabilities to evaluate and to control the possible variation on echocardiographic image interpretation of CALs in Hsueh et al's study. 22 The previous studies have shown a correlation of high IL-10 expression concentrations with acute KD, 7,9,25 but do not answer the question of whether high concentrations of IL-10 are simply a byproduct of acute KD, or whether IL-10 plays a role in the disease process. IL-10 is an anti-inflammatory cytokine, and early clinical trials show that IL-10 has a good safety profile and potential therapeutic use in treatment of autoimmune and inflammatory conditions. 16 Elevated IL-10 serum concentrations are associated with a more favorable prognosis in patients with acute coronary syndromes. 26 We postulate that high IL-10 concentration might decrease the risk of CALs for acute KD. Claudino et al showed a significantly lower level of IL-10 mRNA was observed from patients with the IL-10 -592 CA or AA genotype, compared to CC. 27 This might explain why KD children with -592 CC genotype were with a significantly reduced risk of acute CALs (AOR =0.21, P=0.008). The haplotypes of ACC, ATA, and GCC have been associated with high, low, and intermediate production of IL-10 separately. 17 In this series, the AOR of ACC is 0.63 and 0.64 with P-value of 0.029 and 0.033 after multivariate analysis (Model I and Model II in Table 4 ). The ACC haplotype might be a genetic marker related to the reduced risk of acute CALs in KD, although the protection effect is quite moderate (1.56-1.59 times).
The association between the ACC haplotype and acute CALs in KD, revealed in this series, could be explained by the following mechanisms. IL-10 is a powerful Th2 cell cytokine, which inhibits the secretion of Th1 cell cytokines. 16 Fu et al reported that in vitro addition of IL-10 in acute KD sera inhibits production of TNF-α, IL-1, etc. 28 In addition, TNF-α activity has been demonstrated to be necessary for both inflammation and vascular damage during development of coronary artery aneurysms in an animal model of KD. 6 A monoclonal antibody against TNF-α, infliximab, has been tested in children who fail to become afebrile after initial IVIG treatment. 29, 30 The ACC haplotype, a high IL-10 producer, might be associated with inhibiting secretion of proinflammatory cytokines and play a protective role in KD. Hence, among ACC-positive individuals, the low susceptibility for acute CALs could be explained by a low release of pro-inflammatory cytokines.
In this series, we demonstrated there is no involvement of IL-10 polymorphisms in CALs in the chronic stage of KD. Several limitations in this study need to be specified. This study was a single-center cohort investigation of patients seen over a period of 19 years, resulting in selection effect on KD patients with CALs in the chronic stage, which has been adjusted in the multiple logistic regression. On account of our retrospective study, IL-10 serum concentration was not measured in patients with acute KD. In this study, the use of Japanese Ministry of Health criteria might underestimate the true incidence of CALs in patients with KD. Our findings about IL-10 polymorphisms might be insufficient to clarify the complex interplays among a number of different genes controlling expression of cytokines in KD. Therefore, replication studies with independent large cohorts are suggested.
In conclusion, C allelic type and CC genotype at 2 promoter polymorphisms located -819 CC and -592 CC of IL-10 and their 3-locus haplotype ACC were associated with the reduced risk of CALs in the acute stage, but not in the chronic stage for Taiwanese KD children. Although the effects of IL-10 genetic polymorphism on CALs in acute stage of KD are important, the persistence of CALs in the chronic stage of KD depends much more on other factors such as the times of IVIG treatment.
